Proprotein convertase subtilisin / keksin type 9 (PCSK9) + control the expression of low density lipoprotein receptor
Keywords:
proprotein convertase subtilisin / kexin 9, receptor LDL, hyperlipidemiaAbstract
New data became available during last decade about the regulation of expression of hepatic low density lipoprotein
receptor (LDL-R) which supplies clearance of LDL particles from the blood. Proprotein convertase subtilisin kexin 9
(PCSK9) was identified and it has been shown that this molecule plays a key role in degradation of LDL-Rs. This leads
to a lower uptake and further catabolism of circulating LDL, as result the concentration of LDL in the serum raises.
Current review is devoted to the discovery of PCSK9, its role in LDL-R degradation, regulation of PCSK9 expression
and to its physiological role.
Downloads
Download data is not yet available.
Downloads
Published
2013-06-28
How to Cite
Kukharchuk V. V., Bazhan S. S. Proprotein convertase subtilisin / keksin type 9 (PCSK9) + control the expression of low density lipoprotein receptor // The Journal of Atherosclerosis and Dyslipidemias. 2013. VOL. № 2 (11). PP. 19–26.
Issue
Section
Review